EDIT
Price
$1.45
Change
+$0.06 (+4.32%)
Updated
May 9 closing price
Capitalization
121.38M
One day until earnings call
RAPT
Price
$0.75
Change
-$0.05 (-6.25%)
Updated
May 9 closing price
Capitalization
99.68M
89 days until earnings call
Ad is loading...

EDIT vs RAPT

Header iconEDIT vs RAPT Comparison
Open Charts EDIT vs RAPTBanner chart's image
Editas Medicine
Price$1.45
Change+$0.06 (+4.32%)
Volume$2.65M
Capitalization121.38M
RAPT Therapeutics
Price$0.75
Change-$0.05 (-6.25%)
Volume$736K
Capitalization99.68M
EDIT vs RAPT Comparison Chart
Loading...
EDIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RAPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EDIT vs. RAPT commentary
May 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EDIT is a Hold and RAPT is a Hold.

Ad is loading...
COMPARISON
Comparison
May 11, 2025
Stock price -- (EDIT: $1.45 vs. RAPT: $0.75)
Brand notoriety: EDIT and RAPT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EDIT: 122% vs. RAPT: 85%
Market capitalization -- EDIT: $121.38M vs. RAPT: $99.68M
EDIT [@Biotechnology] is valued at $121.38M. RAPT’s [@Biotechnology] market capitalization is $99.68M. The market cap for tickers in the [@Biotechnology] industry ranges from $296.96B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EDIT’s FA Score shows that 1 FA rating(s) are green whileRAPT’s FA Score has 0 green FA rating(s).

  • EDIT’s FA Score: 1 green, 4 red.
  • RAPT’s FA Score: 0 green, 5 red.
According to our system of comparison, EDIT is a better buy in the long-term than RAPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EDIT’s TA Score shows that 5 TA indicator(s) are bullish while RAPT’s TA Score has 3 bullish TA indicator(s).

  • EDIT’s TA Score: 5 bullish, 5 bearish.
  • RAPT’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, EDIT is a better buy in the short-term than RAPT.

Price Growth

EDIT (@Biotechnology) experienced а -11.59% price change this week, while RAPT (@Biotechnology) price change was -22.06% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.24%. For the same industry, the average monthly price growth was +9.39%, and the average quarterly price growth was -13.47%.

Reported Earning Dates

EDIT is expected to report earnings on Jul 30, 2025.

RAPT is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (-6.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EDIT($121M) has a higher market cap than RAPT($99.7M). EDIT YTD gains are higher at: 14.173 vs. RAPT (-52.310). RAPT has higher annual earnings (EBITDA): -134.9M vs. EDIT (-233.11M). EDIT has more cash in the bank: 270M vs. RAPT (231M). RAPT has less debt than EDIT: RAPT (4.49M) vs EDIT (35M). EDIT has higher revenues than RAPT: EDIT (32.3M) vs RAPT (0).
EDITRAPTEDIT / RAPT
Capitalization121M99.7M121%
EBITDA-233.11M-134.9M173%
Gain YTD14.173-52.310-27%
P/E RatioN/AN/A-
Revenue32.3M0-
Total Cash270M231M117%
Total Debt35M4.49M779%
FUNDAMENTALS RATINGS
EDIT: Fundamental Ratings
EDIT
OUTLOOK RATING
1..100
29
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
53
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EDITRAPT
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 13 days ago
83%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
82%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Ad is loading...
EDIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RAPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DMEHF0.15N/A
+3.19%
Desert Mountain Energy Corp.
AIQUF206.942.07
+1.01%
L'Air Liquide SA
FPAFY3.52-0.05
-1.26%
First Pacific Company Ltd.
AMKBY8.52-0.17
-1.93%
A.P. Moeller-Maersk A/S
CHEOY83.67-3.56
-4.08%
CochLear Ltd.

EDIT and

Correlation & Price change

A.I.dvisor indicates that over the last year, EDIT has been loosely correlated with CRSP. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if EDIT jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EDIT
1D Price
Change %
EDIT100%
+4.32%
CRSP - EDIT
54%
Loosely correlated
-1.44%
AXON - EDIT
52%
Loosely correlated
-0.33%
PRME - EDIT
52%
Loosely correlated
-1.52%
NTLA - EDIT
50%
Loosely correlated
-1.93%
VCYT - EDIT
49%
Loosely correlated
-4.81%
More

RAPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RAPT has been closely correlated with JBPHF. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if RAPT jumps, then JBPHF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RAPT
1D Price
Change %
RAPT100%
-5.81%
JBPHF - RAPT
79%
Closely correlated
N/A
AXON - RAPT
48%
Loosely correlated
-0.33%
SNDX - RAPT
45%
Loosely correlated
-2.82%
TRAW - RAPT
44%
Loosely correlated
-5.00%
AGIO - RAPT
41%
Loosely correlated
-2.57%
More